Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 USD | +0.29% | -0.50% | -13.72% |
Financials (USD)
Sales 2024 * | 656M | Sales 2025 * | 719M | Capitalization | 1.78B |
---|---|---|---|---|---|
Net income 2024 * | -70M | Net income 2025 * | -49M | EV / Sales 2024 * | 3.12 x |
Net Debt 2024 * | 265M | Net Debt 2025 * | 238M | EV / Sales 2025 * | 2.81 x |
P/E ratio 2024 * |
-24.9
x | P/E ratio 2025 * |
-37
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.82% |
Latest transcript on NeoGenomics, Inc.
1 day | +0.29% | ||
1 week | -0.50% | ||
Current month | +0.29% | ||
1 month | -9.29% | ||
3 months | -5.68% | ||
6 months | +1.38% | ||
Current year | -13.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 22-12-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Crowther
BRD | Director/Board Member | 72 | 14-10-21 |
Michael Kelly
BRD | Director/Board Member | 67 | 20-07-14 |
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.43% | 16 M€ | -5.68% | ||
0.97% | 11 M€ | -6.03% | - | |
0.29% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 13.96 | +0.29% | 1,186,906 |
24-04-30 | 13.92 | -8.54% | 2,369,456 |
24-04-29 | 15.22 | +7.64% | 2,383,110 |
24-04-26 | 14.14 | +2.09% | 830,782 |
24-04-25 | 13.85 | -1.28% | 792,553 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.72% | 1.78B | |
-18.52% | 8.35B | |
+45.10% | 3.58B | |
-8.06% | 2.47B | |
-38.71% | 2.46B | |
-7.96% | 2.36B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B | |
-11.50% | 1.09B |
- Stock Market
- Equities
- NEO Stock